Insight Molecular Diagnostics (IMDX) Return on Sales [ROS] (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Return on Sales [ROS] of -4770.71% for Q2 2026, down 2870.71 percentage points from -1900.00% a year earlier but up 9019.91 percentage points from the prior quarter.
Insight Molecular Diagnostics (IMDX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Insight Molecular Diagnostics was -3011.86%, down 1513.55 percentage points year-over-year; for FY2025, it was -1260.76%, up 1984.37 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +1182.57 percentage points (FY2020 to FY2025).
- In prior years, Insight Molecular Diagnostics' Return on Sales [ROS] was -3245.14% in FY2024 (-1572.75 pp), -1672.39% in FY2023 (+206.21 pp), -1878.60% in FY2022 (+565.67 pp) and -2444.27% in FY2021 (-0.93 pp).
- Quarterly Return on Sales [ROS] has run from a low of -13790.63% in Q1 2026 to a high of 1969.70% in Q1 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of -1059.77 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2025, with a gain of 7502.94 percentage points; the weakest was Q1 2026, with a drop of 13472.62 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -13790.63% (Q1 2026), -2057.51% (Q4 2025) and -4249.23% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 33.60% |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 21.65% |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 29.48% |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 13.31% |
| 10 | Insight Molecular Diagnostics | 112.22 Mn | 35.94 Mn | 157,000.00 | -4,770.71% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,770.71% |
| Mar 31, 2026 | -13,790.63% |
| Dec 31, 2025 | -2,057.51% |
| Sep 30, 2025 | -4,249.23% |
| Jun 30, 2025 | -1,900.00% |
| Mar 31, 2025 | -318.01% |
| Dec 31, 2024 | -2,262.92% |
| Sep 30, 2024 | -11,752.17% |
| Jun 30, 2024 | -4,453.85% |
| Mar 31, 2024 | -5,265.34% |
| Dec 31, 2023 | -5,152.55% |
| Sep 30, 2023 | -1,518.18% |
| Jun 30, 2023 | -1,791.36% |
| Mar 31, 2023 | 1,969.70% |
| Dec 31, 2022 | -4,251.09% |
| Sep 30, 2022 | -2,546.27% |
| Jun 30, 2022 | -686.08% |
| Mar 31, 2022 | -793.95% |
| Dec 31, 2021 | -994.15% |
| Sep 30, 2021 | -1,382.52% |
Insight Molecular Diagnostics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();